Home
>
US Stocks
>
Prothena Corporation plc
Prothena Corporation plc
PRTA

Prothena Corporation plc (PRTA)

$54.6312.83%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$59.52
Today Low/High$54.63 / $60.62
52 Week Low/High$10.72 / $79.75
P/E ratio-36.32
Market Cap$2.77B

Company Details

Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena’s partnered programs include prasinezumab (PRX002/RG7935), in collaboration with Roche for the potential treatment of Parkinson’s disease and other related synucleinopathies, and programs that target tau (PRX005), TDP-43 and an undisclosed target in collaboration with Bristol-Myers Squibb for the potential treatment of Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) or other neurodegenerative diseases. Prothena’s wholly-owned programs include PRX004 for the potential treatment of ATTR amyloidosis, and a portfolio of programs for the potential treatment of Alzheimer’s disease including PRX012 that targets Aß (Amyloid beta).
OrganisationProthena Corporation plc
HeadquatersDublin, Dublin, Ireland
Employees66
IndustryHealth Technology
CEOGene Kinney

Discover more

Frequently Asked Questions

What is Prothena Corporation plc (PRTA) share price today?

Can Indians buy Prothena Corporation plc (PRTA) shares?

How can I buy Prothena Corporation plc (PRTA) shares from India?

Can Fractional shares of Prothena Corporation plc (PRTA) be purchased?

What are the documents required to start investing in Prothena Corporation plc (PRTA) stocks?

We are a SEBI registered investement advisor